A Phase 1 Study of Navlimetostat Tablet Formulations

Recruiting

Phase 1

NavlimetostatA Phase 1 Study of Navlimetostat Tablet Formulations

Sponsor:

Bristol-Myers Squibb

Code:

NCT07544628

Conditions

Healthy Participants

Eligibility Criteria

Sex: Female

Age: 18 - 55

Healthy Volunteers: Accepted

Interventions

Navlimetostat

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-06-04. This information was provided to ClinicalTrials.gov by Bristol-Myers Squibb on 2026-05-14.